Showing 7961-7970 of 18164 results for "".
Recognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
https://reachmd.com/programs/dermconsult/pso-hs-subset-genetic-risk/39676/Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
https://reachmd.com/programs/neurofrontiers/sabirnetug-early-alzheimers/40000/Advances in Heart Failure Care: FINEARTS-HF Findings on Finerenone
https://reachmd.com/programs/Audioabstracts/advances-in-heart-failure-care-finearts-hf-findings-on-finerenone/35908/While steroidal mineralocorticoid receptor antagonists (MRAs) are known to be beneficial for patients with heart failure and reduced ejection fraction, their role in treating patients with mildly reduced or preserved ejection fraction has only recently been explored in the FINEARTS-HF study. This stBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/balancing-efficacy-and-tolerability-in-metastatic-breast-cancer-treatment/35459/When making treatment decisions for patients with metastatic breast cancer, acknowledging both efficacy and tolerability is key. Dr. Paolo Tarantino joins the program to explain how patient-specific factors and timely treatment changes can help optimize outcomes. Dr. Tarantino is a medical oncologisReducing Food Allergy Reactions with an Asthma Treatment
https://reachmd.com/programs/frontlines-food-allergies/reducing-food-allergy-reactions-with-an-asthma-treatment/26318/GLP-1RA reduces risk of CV events associated with overweight and obesity
https://reachmd.com/cme/obesity/glp-1ra-reduces-risk-of-cv-events-associated-with-overweight-and-obesity/17778/3' education - Nov. 11, 2023 - Michael Lincoff, MDA Review of Biosimilars in Retina
https://reachmd.com/programs/eye-on-ocular-health/a-review-of-biosimilars-in-retina/15971/Tune in as we review current and past literature regarding the use of biosimilars in the retina.Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
https://reachmd.com/programs/cme/current-standards-and-future-opportunities-for-adcs-in-advancedmetastatic-triple-negative-breast-cancer/14551/Are you ready and willing to change your treatment approach for your patients with TNBC? Our experts break down the guidelines to get you on track.The New COVID-19 Booster: Updates & Changes You Need to Know
https://reachmd.com/programs/covid-19-frontlines/the-new-covid-19-booster-updates-changes-you-need-to-know/14204/The new COVID-19 booster is ready for patients to receive. What do we need to know about this new vaccine?AI in Neurology: What Tools Are Emerging?
https://reachmd.com/programs/neurofrontiers/ai-in-neurology-what-tools-are-emerging/13727/With AI technologies on the rise, we’re taking a look at what this could mean for the field of neurology.